KPV – Anti-Inflammatory Research Peptide

KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment derived from α-melanocyte-stimulating hormone (α-MSH) investigated for anti-inflammatory signaling pathway modulation in laboratory models. This bioactive tripeptide has been studied for its interaction with immune cell populations, NF-κB pathway inhibition, cytokine expression regulation, and inflammatory mediator suppression in various tissue systems under controlled experimental conditions.

Research Applications:

• NF-κB pathway modulation and transcription factor activity studies
• Pro-inflammatory cytokine expression profiling (TNF-α, IL-6, IL-1β)
• Immune cell activation state analysis in macrophage and dendritic cell models
• Inflammatory mediator release quantification (prostaglandins, nitric oxide)
• Cellular migration pattern investigation in inflammation models
• Tissue response mechanism characterization in epithelial barrier models
• Peptide uptake and cellular internalization kinetics
• Anti-inflammatory peptide SAR (structure-activity relationship) studies

Specifications:

• Purity: >98% (HPLC verified)
• Sequence: Lys-Pro-Val (C₁₆H₃₀N₄O₄)
• Molecular Weight: 342.43 g/mol
• CAS Number: 27214-00-2
• Supplied as: Lyophilized powder in sealed vials
• Available doses: 5mg, 10mg
• Storage: -20°C, protect from light and moisture
• Each batch includes Certificate of Analysis (COA)

Manufactured with pharmaceutical-grade quality standards to ensure consistency in anti-inflammatory mechanism research.

For laboratory research use only. Not for human consumption.